Peptide stacking means using two or more peptides together in a planned way, instead of using just one peptide at a time. The idea is that different peptides may work on different systems in the body, such as growth hormone signaling, recovery, metabolism, inflammation, tissue repair, or mitochondrial function. For example, someone might combine a peptide that supports growth hormone release with another peptide aimed at recovery or connective tissue support.
The popularity of peptide stacking has grown because more people are interested in performance, body composition, recovery, and longevity. Telehealth, social media, biohacking communities, and easier access to advanced lab testing have all helped drive this trend. But it is important to understand that many stacking protocols are based more on theory, physiology, and real-world clinical experience than on large, high-quality human trials studying specific combinations.
Potential goals of peptide stacking may include improved body composition, better recovery, improved sleep, metabolic support, reduced inflammation, healthier skin, or support for cellular energy. However, stacking is not always better. A single-peptide approach is simpler, easier to monitor, and often the safest place to start. Adding multiple peptides increases complexity and makes it harder to know what is working or what may be causing side effects.
A responsible peptide protocol should be guided by data, not trends. Useful markers may include IGF-1, fasting insulin, hemoglobin A1c, inflammation markers such as hs-CRP, lipid testing, thyroid function, liver and kidney markers, and body composition testing such as DEXA. Symptoms, sleep, recovery, strength, appetite, and side effects should also be tracked.
In short, peptide stacking is a systems-based approach to optimization. It may make sense in select cases when supervised by a qualified medical professional and guided by biomarkers. But it should not be viewed as a one-size-fits-all shortcut. The safest approach is individualized, measured, and medically supervised.
Popular peptide stacks
1. Longevity-Focused Peptide Stacks
Commonly Discussed Stack: CJC-1295 + Ipamorelin + MOTS-c
Rationale: Growth hormone secretagogues (CJC-1295 and Ipamorelin) support endogenous GH pulsatility, while MOTS-c is studied for mitochondrial and metabolic signaling support.
Commonly Discussed Dosing Ranges:
• CJC-1295 (no DAC): 100–200 mcg, 1–2x daily
• Ipamorelin: 100–300 mcg, 1–2x daily
• MOTS-c: 5–15 mg, 2–3x weekly (cycled 4–6 weeks)
2. Inflammation Management Stacks
Commonly Discussed Stack: BPC-157 + TB-500 + Thymosin Alpha-1
Rationale: These peptides are discussed in performance medicine circles for tissue repair, actin regulation, and immune modulation.
Commonly Discussed Dosing Ranges:
• BPC-157: 250–500 mcg, 1–2x daily
• TB-500: 2–5 mg weekly for 4–6 weeks
• Thymosin Alpha-1: 1.0–1.5 mg, 2x weekly
3. Gut Health & Mucosal Support Stacks
Commonly Discussed Stack: BPC-157 + KPV
Rationale: BPC-157 is often discussed for gastrointestinal mucosal repair, while KPV is studied for inflammatory cytokine modulation.
Commonly Discussed Dosing Ranges:
• BPC-157: 250–500 mcg, 1–2x daily
• KPV: 200–500 mcg, 1–2x daily
4. Fat Loss & Metabolic Optimization Stacks
Commonly Discussed Stack: GLP-1 Agonist + GH Secretagogue + AOD-9604
Rationale: GLP-1 receptor agonists regulate appetite and glycemia, GH secretagogues may support lean mass preservation, and AOD-9604 is discussed for lipolysis signaling.
Commonly Discussed Dosing Ranges:
• Semaglutide: 0.25 mg weekly, titrated up to 1.0–2.4 mg weekly
• Tirzepatide: 2.5 mg weekly, titrated up to 10–15 mg weekly
• AOD-9604: 300–500 mcg daily
• CJC-1295 + Ipamorelin: 100–200 mcg each nightly
5. Muscle Repair & Growth Stacks
Commonly Discussed Stack: CJC-1295 + Ipamorelin + IGF-1 LR3 + BPC-157
Rationale: This stack is discussed in performance settings for growth signaling and tissue repair support. IGF-1 LR3 is more aggressive and requires careful physician monitoring.
Commonly Discussed Dosing Ranges:
• CJC-1295: 100–200 mcg, 1–2x daily
• Ipamorelin: 100–300 mcg, 1–2x daily
• IGF-1 LR3: 20–50 mcg daily (often cycled 4–6 weeks)
• BPC-157: 250–500 mcg daily
Both consumers and physicians should understand that stacking increases complexity. Monitoring may include:
• IGF-1 levels
• Fasting glucose and insulin
• Hemoglobin A1c
• Lipid panel
• hs-CRP
• Liver and kidney function
• Body composition tracking
References
Melmed S. Growth hormone physiology. J Clin Endocrinol Metab.
Petersen MC & Shulman GI. Insulin resistance mechanisms. N Engl J Med.
Longo VD et al. Hallmarks of aging interventions. Cell.
Müller TD et al. GLP-1 receptor biology. Nat Rev Endocrinol.
Mechanick JI et al. Precision metabolic medicine. Endocrine Practice.